Neuronetics Q1 2026: Revenue Surges, Cost Cuts, and New Sales Models episode artwork

EPISODE · May 5, 2026 · 2 MIN

Neuronetics Q1 2026: Revenue Surges, Cost Cuts, and New Sales Models

from The Daily News Now! Business

Neuronetics Q1 2026 earnings show a 8% revenue increase to $34.5M, driven by a 15% jump in U.S. clinics revenue. NeuroStar system sales rose by 10% despite a 3% overall decline. Cost cuts and new sales models are expected to boost efficiency. Net losses narrowed to $10.8M, and cash flow is projected to turn positive in the second half. Guidance remains steady, with a focus on clinic efficiency, broader NeuroStar reach, and potential new therapies. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/4bd3581f6c07c84d

NOW PLAYING

Neuronetics Q1 2026: Revenue Surges, Cost Cuts, and New Sales Models

0:00 2:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 2 minutes long.

When was this The Daily News Now! Business episode published?

This episode was published on May 5, 2026.

What is this episode about?

Neuronetics Q1 2026 earnings show a 8% revenue increase to $34.5M, driven by a 15% jump in U.S. clinics revenue. NeuroStar system sales rose by 10% despite a 3% overall decline. Cost cuts and new sales models are expected to boost efficiency....

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!